Plus Therapeutics | CYTX - Current Liabilities

Stock Price
0.30
Daily Change
-0.01 -4.21%
Monthly
13.89%
Yearly
-79.44%
Q1 Forecast
0.29

Plus Therapeutics reported $10.73M in Current Liabilities for its fiscal quarter ending in December of 2023.





Current Liabilities Change Date
Baxter International USD 2.97B 805M Dec/2025
Cerus USD 88.43M 4.08M Sep/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Northwest Biotherapeutics USD 87.9M 3.98M Sep/2025
Plus Therapeutics USD 10.73M 189K Dec/2023
Sanofi EUR 28.35B 3.76B Dec/2025
Starpharma Holdings AUD 4.61M 614K Dec/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025